| Ident. | Authors (with country if any) | Title |
|---|
| 000041 (2020) |
Youjiang Li [République populaire de Chine] ; Yingying Hu [République populaire de Chine] ; Xiaodong Zhang [République populaire de Chine] ; Yuanyuan Yu [République populaire de Chine] ; Bin Li [République populaire de Chine] ; Jianguo Wu [République populaire de Chine] ; Yingping Wu [République populaire de Chine] ; Xiaoping Xia [République populaire de Chine] ; Jian Xu [République populaire de Chine] | [Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)]. |
| 000091 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000521 (2020) |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
| 000573 (2020) |
Tianyi Qiu [République populaire de Chine] ; Tiantian Mao [République populaire de Chine] ; Yuan Wang [République populaire de Chine] ; Mengdi Zhou [République populaire de Chine] ; Jingxuan Qiu [République populaire de Chine] ; Jianwei Wang [République populaire de Chine] ; Jianqing Xu [République populaire de Chine] ; Zhiwei Cao [République populaire de Chine] | Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus. |
| 000766 (2020) |
Daniel J. Drucker [Canada] | Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. |
| 000A86 (2019) |
Kaijun Jin [République populaire de Chine] ; Yali Sang [République populaire de Chine] ; Sheng Han [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Ge Meng [République populaire de Chine] ; Fener Chen [République populaire de Chine] | Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains. |
| 000B96 (2018-09) |
Cyril Fersing [France] ; Clotilde Boudot [France] ; Julien Pedron [France] ; Sébastien Hutter [France] ; Nicolas Primas [France] ; Caroline Castera-Ducros [France] ; Sandra Bourgeade-Delmas [France] ; Alix Sournia-Saquet [France] ; Alain Moreau [France] ; Anita Cohen [France] ; Jean-Luc Stigliani [France] ; Geneviève Pratviel [France] ; Maxime Crozet [France] ; Susan Wyllie [Royaume-Uni] ; Alan Fairlamb [Royaume-Uni] ; Alexis Valentin [France] ; Pascal Rathelot [France] ; Nadine Azas [France] ; Bertrand Courtioux [France] ; Pierre Verhaeghe [France] ; Patrice Vanelle [France] | 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases |
| 000D26 (2018) |
Dinakaran Murugesan [Royaume-Uni] ; Peter C. Ray [Royaume-Uni] ; Tracy Bayliss [Royaume-Uni] ; Gareth A. Prosser [États-Unis] ; Justin R. Harrison [Royaume-Uni] ; Kirsteen Green [Royaume-Uni] ; Candice Soares De Melo [Afrique du Sud] ; Tzu-Shean Feng [Afrique du Sud] ; Leslie J. Street [Afrique du Sud] ; Kelly Chibale [Afrique du Sud] ; Digby F. Warner [Afrique du Sud] ; Valerie Mizrahi [Afrique du Sud] ; Ola Epemolu [Royaume-Uni] ; Paul Scullion [Royaume-Uni] ; Lucy Ellis [Royaume-Uni] ; Jennifer Riley [Royaume-Uni] ; Yoko Shishikura [Royaume-Uni] ; Liam Ferguson [Royaume-Uni] ; Maria Osuna-Cabello [Royaume-Uni] ; Kevin D. Read [Royaume-Uni] ; Simon R. Green [Royaume-Uni] ; Dirk A. Lamprecht [Afrique du Sud] ; Peter M. Finin [Afrique du Sud] ; Adrie J. C. Steyn [Afrique du Sud, États-Unis] ; Thomas R. Ioerger [États-Unis] ; Jim Sacchettini [États-Unis] ; Kyu Y. Rhee [États-Unis] ; Kriti Arora [États-Unis] ; Clifton E. Barry [États-Unis, Afrique du Sud] ; Paul G. Wyatt [Royaume-Uni] ; Helena I. M. Boshoff [États-Unis] | 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and
Absorption, Distribution, Metabolism, and Excretion Characterization |
| 000D45 (2017) |
Woo-Jin Shin [États-Unis] ; Baik Lin Seong [Corée du Sud] | Type II transmembrane serine proteases as potential target for anti-influenza drug discovery. |
| 000D54 (2017) |
Yong Hu ; Wei Li ; Ting Gao ; Yan Cui ; Yanwen Jin ; Ping Li ; Qingjun Ma ; Xuan Liu ; Cheng Cao | The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination |
| 000D89 (2017) |
Su-Hua Huang [Taïwan] ; Tzu-Ying Lee [Taïwan] ; Ying-Ju Lin [Taïwan] ; Lei Wan [Taïwan] ; Chih-Ho Lai [Taïwan] ; Cheng-Wen Lin [Taïwan] | Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism. |
| 000D99 (2017) |
Maude Pauly [Luxembourg (pays)] ; Jacques B. Pir [Luxembourg (pays)] ; Catherine Loesch [Luxembourg (pays)] ; Aurélie Sausy [Luxembourg (pays)] ; Chantal J. Snoeck [Luxembourg (pays)] ; Judith M. Hübschen [Luxembourg (pays)] ; Claude P. Muller [Luxembourg (pays)] | Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg |
| 000E65 (2017) |
Jung-Sheng Yu [Taïwan] ; Chin-Kai Tseng [Taïwan] ; Chun-Kuang Lin [Taïwan] ; Yao-Chin Hsu [Taïwan] ; Yu-Hsuan Wu [Taïwan] ; Ching-Liang Hsieh [Taïwan] ; Jin-Ching Lee [Taïwan] | Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses. |
| 000F37 (2016) |
Gaopeng Song [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yibin Li [République populaire de Chine] ; Hongzong Si [République populaire de Chine] ; Jihong Fan [République populaire de Chine] ; Junhua Li [République populaire de Chine] ; Erqiang Gao [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] | Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors. |
| 000F85 (2016) |
Pak-Yin Lui [République populaire de Chine] ; Lok-Yin Roy Wong [République populaire de Chine] ; Cheuk-Lai Fung [République populaire de Chine] ; Kam-Leung Siu [République populaire de Chine] ; Man-Lung Yeung [République populaire de Chine] ; Kit-San Yuen [République populaire de Chine] ; Chi-Ping Chan [République populaire de Chine] ; Patrick Chiu-Yat Woo [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Dong-Yan Jin [République populaire de Chine] | Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. |
| 001037 (2016) |
Rudragouda Channappanavar [États-Unis] ; Anthony R. Fehr [États-Unis] ; Rahul Vijay [États-Unis] ; Matthias Mack [Allemagne] ; Jincun Zhao [États-Unis, République populaire de Chine] ; David K. Meyerholz [États-Unis] ; Stanley Perlman [États-Unis] | Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice |
| 001437 (2015) |
| PERFORMANCE OF A PREDICTIVE ALGORITHM IN SENSOR‐AUGMENTED PUMP THERAPY IN THE PREVENTION OF HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES |
| 001585 (2014) |
Xiaojuan Chen [République populaire de Chine] ; Xingxing Yang ; Yang Zheng ; Yudong Yang ; Yaling Xing ; Zhongbin Chen | SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. |
| 001840 (2013) |
Wooseong Lee [Corée du Sud] ; Seung-Hoon Lee ; Dae-Gyun Ahn ; Hee Cho ; Moon-Hee Sung ; Seung Hyun Han ; Jong-Won Oh | The antiviral activity of poly-γ-glutamic acid, a polypeptide secreted by Bacillus sp., through induction of CD14-dependent type I interferon responses. |
| 001851 (2013) |
Gyorgy J. Simon [États-Unis] ; John Schrom [États-Unis] ; M. Regina Castro [États-Unis] ; Peter W. Li [États-Unis] ; Pedro J. Caraballo [États-Unis] | Survival Association Rule Mining Towards Type 2 Diabetes Risk Assessment |
| 001858 (2013) |
Fay Probert [Royaume-Uni] ; Sara B-M Whittaker ; Max Crispin ; Daniel A. Mitchell ; Ann M. Dixon | Solution NMR analyses of the C-type carbohydrate recognition domain of DC-SIGNR protein reveal different binding modes for HIV-derived oligosaccharides and smaller glycan fragments. |
